Ara Parseghian Medical Research Foundation
- Assets
- $0.0
- Revenue
- $241.1k
- Investments
- $0.0
- Employees
- 3
- Location
- Tucson, AZ
- Founding
- 12/1994
- Data as of
- 06/2017
- EIN
- 86-0775966
Organization Overview
Ara Parseghian Medical Research Foundation is located in Tucson, AZ. The organization was established in 1994. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 06/2017, Ara Parseghian Medical Research Foundation employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ara Parseghian Medical Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2017, Ara Parseghian Medical Research Foundation generated $241.1k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 2 years, the organization has seen revenues fall by an average of (49.7%) each year. All expenses for the organization totaled $295.9k during the year ending 06/2017. As we would expect to see with falling revenues, expenses have declined by (55.3%) per year over the past 2 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2017
Describe the Organization's Mission:
Part 3 - Line 1
TO PROMOTE RESEARCH TARGETED AT THE UNDERSTANDING AND CURE OF NIEMANN PICK TYPE C (NP-C) DISEASE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE ARA PARSEGHIAN MEDICAL RESEARCH FOUNDATION'S PURPOSE IS TO PROMOTE RESEARCH THAT IS TARGETED TOWARD UNDERSTANDING THE MOLECULAR BASIS OF NIEMANN PICK TYPE C (NP-C) DISEASE AND DEVELOPING NOVEL THERAPEUTIC STRATEGIES TO TREAT AND/OR CURE THE DISEASE. AS NP-C DISEASE APPEARS TO BE CAUSED BY A DEFECT IN INTRACELLULAR CHOLESTEROL TRAFFICKING, THESE STUDIES SHOULD PROVIDE FUNDAMENTAL INSIGHTS INTO CHOLESTEROL HOMEOSTASIS AND AS SUCH WILL ALSO SERVE TO INCREASE UNDERSTANDING OF ATHEROSCLEROSIS AND MYOCARDIAL INFARCTION, THE LEADING CAUSE OF MORBIDITY AND MORTALITY IN THE UNITED STATES. IN THE YEAR ENDED JUNE 30, 2017, THE ORGANIZATION AWARDED RESEARCH GRANTS TO 1 MAJOR RESEARCH UNIVERSITY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Bernard A Buescher ESQ Director | Trustee | 1 | $0 |
James F Burke ESQ Director | Trustee | 1 | $0 |
Arthur J Decio Director | Trustee | 1 | $0 |
Dr Michael S Parmacek Director | Trustee | 1 | $0 |
Ara Michael Parseghian Director | Trustee | 1 | $0 |
Ara R Parseghian Chairman Of The Board | OfficerTrustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $242,481 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $242,481 |
| Total Program Service Revenue | $0 |
| Investment income | $2 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$1,388 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $241,095 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $251,374 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $8,377 |
| Advertising and promotion | $0 |
| Office expenses | $17,404 |
| Information technology | $1,030 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $16,931 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $806 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $295,922 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $0 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Unrestricted restricted net Assets | $0 |
| Temporarily restricted net Assets | $0 |
| Permanently restricted net Assets or current funds | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Total net assets or fund balances | $0 |
Grants Awarded
Over the last fiscal year, Ara Parseghian Medical Research Foundation has awarded $588,698 in support to 8 organizations.
| Grant Recipient | Amount |
|---|---|
PURDUE UNIVERSITY PURPOSE: MEDICAL RESEARCH. | $84,932 |
CORNELL UNIVERSITY PURPOSE: MEDICAL RESEARCH. | $75,000 |
STANFORD UNIVERSITY PURPOSE: MEDICAL RESEARCH. | $100,000 |
WASHINGTON UNIVERSITY PURPOSE: MEDICAL RESEARCH. | $37,500 |
COLUMBIA UNIVERSITY PURPOSE: MEDICAL RESEARCH. | $75,000 |
RUTGERS STATE UNIVERSITY NEW JERSEY PURPOSE: REFUND OF PRIOR YEAR GRANT. | -$93,500 |